Results 101 to 108 of about 680 (108)

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

Lancet, The, 2003
Tom Solomon, Nicholas J White
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly  

Drotrecogin Alfa (Activated) in Adults with Septic Shock

New England Journal of Medicine, 2012
Ivor S Douglas, Simon R Finfer, John C Marshall   +2 more
exaly  

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

Lancet, The, 2010
Patrick Royston
exaly  

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

Lancet, The, 2001
exaly  

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

New England Journal of Medicine, 2019
Stuart J Connolly, Mark Crowther, John W. Eikelboom   +2 more
exaly  

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

New England Journal of Medicine, 2005
George Lau, Satawat Thongsawat, Edward Gane   +2 more
exaly  

Velaglucerase alfa

Nature Reviews Drug Discovery, 2010
Johannes M F G Aerts
exaly